Minerva (BEEF3.SA) Aandeel Koers
Minerva Koers
In de afgelopen 19 jaar liet Minerva de omzet jaarlijks met 22,3% groeien tot 54,83 Miljard BRL. De winst per aandeel is de afgelopen 19 jaar met 0,1% per jaar gedaald. Bij Minerva is de nettowinstmarge met 1,5% ten opzichte van 2,2% enkele jaren geleden grotendeels stabiel. Op de huidige koers komt het dividendrendement uit op ongeveer 6,30%. De uitkeringsratio ligt rond 24% van de winst. Het dividend is de afgelopen 17 jaar met 1,9% per jaar gegroeid. Het consensus-koersdoel voor Minerva op 12 maanden bedraagt 8,16 BRL, circa 212,6% boven de huidige koers. Van de 17 analisten geven 10 het aandeel een koopadvies — per saldo een Kopen-consensus.
Minerva aandeelkoers
Deze data ophalen via de Eulerpool API
100.000 requests/maand gratis · geen creditcard
Minerva bedrijfsmodel & aandelenanalyse
Veelgestelde vragen over Minerva
Minerva SA represents values of integrity, innovation, and sustainability in its corporate philosophy. As a leading company in the protein industry, Minerva SA is committed to delivering high-quality products while ensuring ethical practices and responsibility towards the environment. With a focus on providing value-added solutions, Minerva SA constantly strives for excellence in animal welfare, food safety, and customer satisfaction. The company's dedication to continuous improvement and robust management practices has earned Minerva SA a trusted reputation in the global market.
The business model of Minerva SA focuses on the production and distribution of animal protein. As a leading company in the agricultural sector, Minerva specializes in beef, mainly for export purposes. With a vertically integrated production chain, Minerva operates feedlots, slaughterhouses, and processing plants to ensure high-quality standards throughout the entire production process. By prioritizing sustainable and efficient practices, Minerva aims to deliver top-quality products to its customers worldwide, meeting the demand for high-protein food sources. As a global provider of animal protein, Minerva SA plays a significant role in the international meat industry.
Minerva SA is primarily active in the meat processing industry.
The main competitors of Minerva SA in the market include JBS SA, BRF SA, and Marfrig Global Foods.
Minerva SA is a prominent company in the meat processing industry. Founded in 1992, Minerva SA quickly rose to prominence as a major player in the global market. Headquartered in Brazil, the company has expanded its operations to various countries, including Uruguay, Paraguay, Colombia, and Argentina. With a focus on beef exports, Minerva SA has become one of the leading exporters of beef products worldwide. The company continually invests in state-of-the-art facilities and innovative technologies to ensure high-quality standards. With a strong commitment to sustainability and animal welfare, Minerva SA has garnered a solid reputation within the industry.
Minerva SA, a leading company in the meat processing industry, has achieved several significant milestones throughout its history. One notable achievement is the company's expansion into international markets, establishing a strong presence in over 100 countries worldwide. Additionally, Minerva SA has continuously invested in technology, enhancing its production efficiency and product quality. The company's commitment to sustainability is another noteworthy milestone, as it has implemented environmentally friendly practices throughout its operations. Minerva SA has also gained recognition for its focus on animal welfare and responsible sourcing, further solidifying its position as a trusted player in the industry.
Minerva SA is primarily present in Brazil and operates in multiple regions across South America.
Analisten hanteren momenteel een gemiddeld koersdoel van 8,22 BRL voor het aandeel Minerva (mediaan: 8,16 BRL), oftewel +215,1 % ten opzichte van de laatste koers. De consensus is gebaseerd op 17 analistenratings.
17 analisten beoordelen het aandeel Minerva momenteel: 10 adviseren kopen, 7 houden en 0 verkopen. Voor 2026 verwachten analisten dat Minerva een omzet van 56,39 Miljard BRL en winst per aandeel van 0,26 BRL behaalt.
Omgezet tegen de huidige wisselkoers noteert het aandeel Minerva op 0,42 EUR (2,61 BRL).
Het aandeel Minerva (BEEF3.SA) is genoteerd aan 2 beurzen, waaronder: B3 (São Paulo) (BEEF3.SA).
The company Minerva SA is a globally active company specializing in the production and distribution of specialty chemicals, as well as providing services in the field of life science. The company was founded in 1948 and is headquartered in Basel, Switzerland. Minerva SA employs approximately 4,000 employees in 40 branches worldwide and is present in over 90 countries. The core business of the company is the production and sale of specialty chemicals. These include raw materials, intermediates and finished products that are used in various industries such as cosmetics, pharmaceuticals, and the chemical industry. A special focus is placed on the development of organic and inorganic molecules that must meet increasingly complex requirements. Research and development also play an important role in this. With state-of-the-art technologies and machinery, new products and processes are developed to meet the high demands of customers. Another pillar of Minerva SA is the field of life science services. This includes the production and storage of biological materials such as DNA, antibodies, and proteins, as well as conducting clinical studies on behalf of clients. Product analysis and quality control are also part of the offering. In addition to its own products and services, Minerva SA also offers comprehensive service offerings. These include technical support and consulting, training, and customer service in various regions. The company places great value on collaboration with its customers and is there to assist them. Minerva SA places special emphasis on sustainability. The company focuses on continuously improving its products and services to have a positive impact on the environment and society. This includes, for example, the use of renewable energy, waste reduction, and the restoration of former industrial areas. In summary, Minerva SA is an internationally successful company specializing in the production and sale of specialty chemicals and services in the field of life science. With a strong focus on innovation and sustainability, the company aims to be a reliable partner for its customers, supporting them in the development of new products and processes.
De verwachte omzet van Minerva bedraagt 56,39 Miljard BRL. Deze cijfers zijn gebaseerd op huidige financiële gegevens en weerspiegelen de bedrijfsresultaten van het bedrijf.
De verwachte winst van Minerva bedraagt 300,96 Miljoen BRL. De nettowinst weerspiegelt de rentabiliteit van het bedrijf na aftrek van alle kosten.
De koers-winstverhouding (P/E) van Minerva bedraagt momenteel 10,17. De P/E-ratio vergelijkt de huidige aandeelkoers met de winst per aandeel en helpt beleggers de waardering van het Minerva-aandeel in te schatten.
De koers-omzetverhouding (P/S) van Minerva bedraagt momenteel 0,05. De P/S-ratio vergelijkt de marktkapitalisatie met de jaarlijkse opbrengsten en dient als waarderingsmaatstaf voor het Minerva-aandeel.
De Eulerpool Kwaliteitsscore voor Minerva is 7/10.
De ISIN van Minerva is BRBEEFACNOR6. De ISIN (International Securities Identification Number) is een wereldwijd unieke identificatie voor wertpapieren.
Het tickersymbool van Minerva is BEEF3.SA. Onder dit beurstickersymbool wordt het Minerva-aandeel op de beurs verhandeld.
Minerva aandeel
Minerva Peer Group
Minerva Ticker
Minerva FIGI
Alle fundamentals en diepgaande analyse van Minerva
Onze aandelenanalyse van het Minerva-aandeel omvat belangrijke financiële kerncijfers zoals de omzet, de winst, de P/E-ratio, de P/S-ratio, de EBIT, evenals informatie over het dividend. Daarnaast bekijken we aspecten zoals aandelen, marktkapitalisatie, schulden, eigen vermogen en verplichtingen van Minerva. Als u meer gedetailleerde informatie zoekt over deze onderwerpen, bieden we op onze subpagina's uitgebreide analyses: